Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer
NCT02540824
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG:
Apatinib single agent arm
Sponsor
Tongji University